Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
February 13, 2023
Characterization of Central Nervous System Clinico-Genomic Outcomes in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Alectinib
Emily Miao, Jordan E Eichholz, Emily S Lebow, et al.
Journal of Neuro-Oncology
|
April 25, 2026
Clinical, molecular, and immunologic determinants of survival in WHO-defined IDH-wildtype glioblastoma treated with radiotherapy: a large real-world cohort study
Cole Friedes, Melanie Berger, Lauren Linkowski, et al.
Journal for Immunotherapy of Cancer
|
November 1, 2023
Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancer
Joao V Alessi, Adam Price, Allison L Richards, et al.
Practical Radiation Oncology
|
July 28, 2022
Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice Guideline
Lia M Halasz, Albert Attia, Lisa Bradfield, et al.
The Oncologist
|
February 15, 2026
Outcomes after SRS and Ipilimumab plus Nivolumab for Melanoma Brain Metastases Following Prior Immune Checkpoint Inhibitor or Targeted Therapy
Ian Messing, Lauren Linkowski, Matthew D Riina, et al.
JCO Precision Oncology
|
September 4, 2024
Early Circulating Tumor DNA Shedding Kinetics for Prediction of Platinum Sensitivity in Patients With Small Cell Lung Cancer
Yonina R Murciano-Goroff, Angela B-Y Hui, Jose A Araujo Filho, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 9, 2021
Corrigendum to "Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions" [Lung Cancer 159 (2021) 66-73]
Sebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 26, 2021
Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions
Sebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
Frontiers in Oncology
|
October 5, 2023
ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy
Emily S Lebow, Narek Shaverdian, Jordan E Eichholz, et al.
Nature Communications
|
June 19, 2021
Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS
A Rose Brannon, Gowtham Jayakumaran, Monica Diosdado, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Lung Cancer (Amsterdam, Netherlands)
|
February 13, 2023
Characterization of Central Nervous System Clinico-Genomic Outcomes in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Alectinib
Emily Miao, Jordan E Eichholz, Emily S Lebow, et al.
Journal of Neuro-Oncology
|
April 25, 2026
Clinical, molecular, and immunologic determinants of survival in WHO-defined IDH-wildtype glioblastoma treated with radiotherapy: a large real-world cohort study
Cole Friedes, Melanie Berger, Lauren Linkowski, et al.
Journal for Immunotherapy of Cancer
|
November 1, 2023
Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancer
Joao V Alessi, Adam Price, Allison L Richards, et al.
Practical Radiation Oncology
|
July 28, 2022
Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice Guideline
Lia M Halasz, Albert Attia, Lisa Bradfield, et al.
The Oncologist
|
February 15, 2026
Outcomes after SRS and Ipilimumab plus Nivolumab for Melanoma Brain Metastases Following Prior Immune Checkpoint Inhibitor or Targeted Therapy
Ian Messing, Lauren Linkowski, Matthew D Riina, et al.
JCO Precision Oncology
|
September 4, 2024
Early Circulating Tumor DNA Shedding Kinetics for Prediction of Platinum Sensitivity in Patients With Small Cell Lung Cancer
Yonina R Murciano-Goroff, Angela B-Y Hui, Jose A Araujo Filho, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 9, 2021
Corrigendum to "Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions" [Lung Cancer 159 (2021) 66-73]
Sebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 26, 2021
Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions
Sebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
Frontiers in Oncology
|
October 5, 2023
ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy
Emily S Lebow, Narek Shaverdian, Jordan E Eichholz, et al.
Nature Communications
|
June 19, 2021
Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS
A Rose Brannon, Gowtham Jayakumaran, Monica Diosdado, et al.
Page
of 5